Theracalcidol Soft Capsule 0.5 Micrograms (Alfacalcidol)

Adult dose

Chronic kidney disease and osteoporosis: Administer orally 0.5 to 1 ㎍ once daily as alfacalcidol. Hypoparathyroidism and other diseases due to vitamin D metabolism disorders: Administer orally 1 to 4 ㎍ once daily.

Child dose

Osteoporosis: Administer orally 0.01 to 0.03 ㎍ per kg of body weight once daily as alfacalcidol. Other conditions: Administer orally 0.05 to 0.1 ㎍ per kg of body weight once daily.

This medication should not be taken by patients with hypercalcemia, hyperphosphatemia, or hypermagnesemia. It should also be avoided in cases where the product of calcium and phosphorus in the blood exceeds a certain value or in cases of alkalosis. Patients with symptoms of vitamin D toxicity or those allergic to this medication or its ingredients should not take it. During treatment with this medication, it is advised to avoid taking magnesium-containing agents, vitamin D and its derivatives, calcium-containing agents, or certain diuretics. For those who are breastfeeding, as the safety of this medication is not established, it is preferable to avoid taking it, and if inevitable, it is advisable to stop breastfeeding. Women who are pregnant or may become pregnant should consult a physician before taking it due to potential toxicity risks to the fetus. Children, elderly individuals, patients taking specific medications, those with a history of kidney stones, or patients with sarcoidosis should consult a professional before taking this medication. If any unusual symptoms or symptoms related to hypercalcemia occur during taking, it should be stopped immediately, and consultation with healthcare professionals is necessary. Serum calcium levels and kidney function should be regularly monitored, and in case of overdose, emergency treatment may be necessary. Adhere strictly to prescribed dosage and dietary guidelines when taking, recognize symptoms of hypercalcemia and take immediate action if abnormalities occur. This medication should be stored in a cool, dry place out of reach of children, avoiding direct sunlight, and should not be transferred to another container.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities with cough + fever, yellowing of skin or eyes (jaundice), extreme fatigue, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination changes

Mild side effects

• Loss of appetite
• nausea
• vomiting
• diarrhea
• constipation
• stomach pain
• abdominal discomfort
• bloating
• dyspepsia
• thirst

This medication should be stored in a lightproof, tightly sealed container and kept at room temperature between 1 degree and 30 degrees Celsius. By doing so, the effectiveness of the medication can be maintained and deterioration can be prevented.

Appearance

Yellow oval soft capsule containing clear or transparent oily content

Package unit

30 capsules/bottle, 100 capsules/bottle, 100 capsules/box [10 capsules/PTPX10]